Sign up
Log in
12 Health Care Stocks Moving In Tuesday's After-Market Session
Share
Listen to the news

Gainers

  • Cognition Therapeutics (NASDAQ:CGTX) shares increased by 8.8% to $0.3 during Tuesday's after-market session. The market value of their outstanding shares is at $18.8 million.
  • Ironwood Pharmaceuticals (NASDAQ:IRWD) stock rose 8.14% to $0.69. The market value of their outstanding shares is at $111.0 million.
  • iBio (NASDAQ:IBIO) shares increased by 8.0% to $0.88. The company's market cap stands at $14.5 million.
  • Geovax Labs (NASDAQ:GOVX) stock moved upwards by 7.77% to $0.97. The company's market cap stands at $14.7 million.
  • Salarius Pharmaceuticals (NASDAQ:SLRX) shares moved upwards by 6.66% to $1.12. The market value of their outstanding shares is at $2.3 million.
  • Helius Medical Tech (NASDAQ:HSDT) stock rose 6.36% to $0.33. The market value of their outstanding shares is at $1.0 million.

Losers

  • Biomea Fusion (NASDAQ:BMEA) shares decreased by 26.2% to $2.14 during Tuesday's after-market session. The market value of their outstanding shares is at $77.5 million.
  • Cardiff Oncology (NASDAQ:CRDF) stock decreased by 16.76% to $3.08. The company's market cap stands at $204.8 million.
  • Beyond Air (NASDAQ:XAIR) stock decreased by 16.26% to $0.24. The company's market cap stands at $20.7 million. As per the press release, Q4 earnings came out today.
  • Eyenovia (NASDAQ:EYEN) stock decreased by 14.35% to $5.97. The market value of their outstanding shares is at $17.2 million.
  • Acurx Pharmaceuticals (NASDAQ:ACXP) shares declined by 8.28% to $0.75. The market value of their outstanding shares is at $17.6 million.
  • Psyence Biomedical (NASDAQ:PBM) shares declined by 6.89% to $4.8. The company's market cap stands at $2.7 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.